These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 29284499

  • 1. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H, Seidelmann SB, Vigneault D, Abbasi SA, Yang E, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Jerosch-Herold M, Bluemke DA, Ho C, Neilan TG.
    J Cardiovasc Magn Reson; 2017 Dec 28; 19(1):107. PubMed ID: 29284499
    [Abstract] [Full Text] [Related]

  • 2. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA.
    Int J Cardiovasc Imaging; 2019 Jul 28; 35(7):1309-1318. PubMed ID: 30790116
    [Abstract] [Full Text] [Related]

  • 3. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Díez J, Jerosch-Herold M, Kwong RY.
    Circ Cardiovasc Imaging; 2013 May 01; 6(3):415-22. PubMed ID: 23549607
    [Abstract] [Full Text] [Related]

  • 4. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT, Silva Vieira M, Kutty S, Lotz J, Hasenfu G, Chiribiri A, Schuster A.
    Invest Radiol; 2017 Mar 01; 52(3):177-185. PubMed ID: 27741021
    [Abstract] [Full Text] [Related]

  • 5. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
    Vigneault DM, Yang E, Jensen PJ, Tee MW, Farhad H, Chu L, Noble JA, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Ho CY, Bluemke DA.
    Radiology; 2019 Mar 01; 290(3):640-648. PubMed ID: 30561279
    [Abstract] [Full Text] [Related]

  • 6. Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.
    Chung H, Kim Y, Park CH, Kim IS, Kim JY, Min PK, Yoon YW, Kim TH, Lee BK, Hong BK, Rim SJ, Kwon HM, Lee KA, Choi EY.
    Cardiovasc Ultrasound; 2021 Jan 06; 19(1):4. PubMed ID: 33407484
    [Abstract] [Full Text] [Related]

  • 7. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
    Germans T, Rüssel IK, Götte MJ, Spreeuwenberg MD, Doevendans PA, Pinto YM, van der Geest RJ, van der Velden J, Wilde AA, van Rossum AC.
    J Cardiovasc Magn Reson; 2010 Mar 15; 12(1):13. PubMed ID: 20230637
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy.
    Tarkiainen M, Sipola P, Jalanko M, Heliö T, Laine M, Järvinen V, Häyrinen K, Lauerma K, Kuusisto J.
    J Cardiovasc Magn Reson; 2016 Jun 04; 18(1):33. PubMed ID: 27259862
    [Abstract] [Full Text] [Related]

  • 9. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y, Yin G, Jiang Y, Song L, Zhao S, Lu M.
    J Cardiovasc Magn Reson; 2020 Jan 02; 22(1):1. PubMed ID: 31898543
    [Abstract] [Full Text] [Related]

  • 10. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
    Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ, HCMNet Investigators.
    JAMA Cardiol; 2017 Apr 01; 2(4):419-428. PubMed ID: 28241245
    [Abstract] [Full Text] [Related]

  • 11. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P, Lawler PR, Ho JE, Correia AW, Abbasi SA, Kwong RY, Jerosch-Herold M, Ho CY, Cheng S.
    Circ Heart Fail; 2016 Sep 01; 9(9):. PubMed ID: 27623770
    [Abstract] [Full Text] [Related]

  • 12. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM, Lakdawala NK, Powell AJ, Evans SP, Cirino AL, Orav EJ, MacRae CA, Colan SD, Ho CY.
    Circ Cardiovasc Genet; 2013 Jun 01; 6(3):230-7. PubMed ID: 23690394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R, Zamorano JL, Fernández-Méndez M, Esteban A, Plaza-Martin M, González-Gómez A, Carbonell A, Rincón LM, Nácher JJJ, Fernández-Golfín C.
    Int J Cardiovasc Imaging; 2019 Jun 01; 35(6):1055-1065. PubMed ID: 30706353
    [Abstract] [Full Text] [Related]

  • 15. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ, Choi HM, Yoon YE, Kim HL, Lee SP, Kim HK, Kim YJ, Cho GY, Zo JH, Sohn DW.
    PLoS One; 2016 Jun 01; 11(6):e0157433. PubMed ID: 27336444
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
    Pöyhönen P, Hiippala A, Ollila L, Kaasalainen T, Hänninen H, Heliö T, Tallila J, Vasilescu C, Kivistö S, Ojala T, Holmström M.
    J Cardiovasc Magn Reson; 2015 Oct 24; 17():89. PubMed ID: 26496977
    [Abstract] [Full Text] [Related]

  • 17. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.
    J Cardiovasc Magn Reson; 2009 Sep 09; 11(1):34. PubMed ID: 19740409
    [Abstract] [Full Text] [Related]

  • 18. The impact of diabetes mellitus on cardiac function assessed by magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Yu SQ, Shi K, Li Y, Wang J, Gao Y, Shi R, Yan WF, Xu HY, Guo YK, Yang ZG.
    Cardiovasc Diabetol; 2024 Aug 08; 23(1):293. PubMed ID: 39118078
    [Abstract] [Full Text] [Related]

  • 19. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O, Unlu S, Kilic DI, Sherif SA, Opan S, Kemal HS, Ozmen E, Tuner H, Bingol G, Barutcu A, Nasifov M, Bakan S, Goktekin O.
    Kardiologiia; 2023 Feb 28; 63(2):52-58. PubMed ID: 36880144
    [Abstract] [Full Text] [Related]

  • 20. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC, Cianciulli TF, Challapa Licidio W, Lax JA, Beck MA, Morita LA, Gagliardi JA, AADELFAAsociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales..
    Echocardiography; 2018 May 28; 35(5):643-650. PubMed ID: 29457264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.